BCAT1 and liver cancer: For example, the decreased methylation level of the BCAT1 promoter in HCC tissues leads to increased BCAT1 expression, over activating the AKT signaling pathway and promoting epithelial-to-mesenchymal transition (EMT), thereby facilitating the occurrence and metastasis of liver cancer cells (78, 79).